CanSino Biologics

Traded on the St. Petersburg Stock Exchange
CanSino Biologics is a Chinese biopharmaceutical company engaged in the research, development and production of vaccines
CanSino Biologics stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

CanSino Biologics balance sheet

Report period2018 2019 2020 2021 2022
End date of the reporting period
Capitalization, CN¥
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

CanSino Biologics cash flows

Report period2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

CanSino Biologics multipliers

Report period2018 2019 2020 2021 2022
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

CanSino Biologics profitability

Report period2018 2019 2020 2021 2022
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
CanSino Biologics assets
CanSino Biologics cash flows
CanSino Biologics dividends
0%

CanSino Biologics shares

TickerNameTypeNominal valueISINPrice
6185:HKCanSino BiologicsCommon share-CNE100003F01HK$16.76
General information
Company nameCanSino Biologics
Tags#hong_kong_spb
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address401-420, Biomedical Park 4th Floor 185 South Avenue TEDA West District Tianjin China
Mailing address401-420, Biomedical Park 4th Floor 185 South Avenue TEDA West District Tianjin China
Websitewww.cansinotech.com